Verified July 2026 · Cited to primary sources
Semax vs Epitalon — evidence grades compared.
The honest verdict
Semax has the stronger evidence (Grade C vs Epitalon's Grade D).
Semax has the edge on evidence. It is Grade C — an approved drug in Russia with real (if unreplicated) clinical studies for cognition and stroke — while Epitalon is Grade D, resting on small, low-quality longevity studies. Both are under FDA review for the July 2026 PCAC vote, so neither has a legal supervised US route today.
Semax vs Epitalon: side by side
| Compared on | Semax | Epitalon |
|---|---|---|
| Evidence grade | Grade C | Grade D |
| Legal status | Under FDA review | Under FDA review |
| Safety | Limited human safety data, no major documented harms | Limited human safety data, no major documented harms |
| Primary use | Cognition & Focus | Sleep |
| Typical cost | UNKNOWN | UNKNOWN |
| One-line verdict | Semax is not FDA-approved (it is approved in Russia) and is under FDA review (July 24, 2026 PCAC). Human evidence is Grade C — real Russian trials, but no Western replication. For the anxiety-focused sister peptide, see our Selank page and our cognitive-peptides hub. | Epitalon is not FDA-approved and is under FDA review (July 24, 2026 PCAC). Human evidence is Grade D — the longevity and anti-aging claims rest on small, low-quality Russian studies. |
| Full review | Full Semax review → | Full Epitalon review → |
Grades and legal status are assigned by our evidence rubric, not by what we can sell. Highlighted cells mark the stronger-evidence side.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
Semax vs Epitalon FAQ
Is Semax better than Epitalon?
On strength of human evidence, Semax grades higher (Grade C vs Epitalon's Grade D). Semax has the edge on evidence. It is Grade C — an approved drug in Russia with real (if unreplicated) clinical studies for cognition and stroke — while Epitalon is Grade D, resting on small, low-quality longevity studies. Both are under FDA review for the July 2026 PCAC vote, so neither has a legal supervised US route today.
Which has stronger human evidence, Semax or Epitalon?
Semax has the stronger evidence (Grade C vs Epitalon's Grade D). We grade every peptide A–F by strength of human evidence: Semax is Grade C (early / foreign human data only) and Epitalon is Grade D (animal studies only, unproven in humans).
Is Semax or Epitalon legal to get?
Semax: regulatory limbo — july 2026 pcac vote pending (Under FDA review — July 2026 PCAC). Epitalon: regulatory limbo — july 2026 pcac vote pending (Under FDA review — July 2026 PCAC). Always confirm current status with a licensed clinician before pursuing either — we don't link gray-market vendors.
Keep comparing
The monthly peptide evidence brief.
What the research and the FDA actually say — one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.